This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: Kiyoaki Sakata: Innovator in Anti-Tumor Compounds
Introduction
Kiyoaki Sakata is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-tumor activities. With a total of 2 patents to his name, Sakata's work is recognized for its potential impact on cancer treatment.
Latest Patents
One of Sakata's latest patents focuses on polycyclic compounds exhibiting anti-tumor activities. This invention concerns novel polycyclic compounds of a specific formula, which includes various defined components and their pharmaceutically acceptable salts. These compounds demonstrate anti-tumor activity and are useful for treating cell proliferative disorders.
Career Highlights
Kiyoaki Sakata is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to explore innovative solutions in drug development, particularly in oncology.
Collaborations
Sakata has collaborated with notable colleagues, including Kenichi Kawasaki and Tatsuo Ohtsuka. These partnerships have contributed to the advancement of research and development in their respective fields.
Conclusion
Kiyoaki Sakata's contributions to the development of anti-tumor compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile